In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Inverness Medical Technology nets $82.9mm in FOPO

Executive Summary

Inverness Medical Technology (glucose monitoring devices) netted about $82.9mm in a follow-on public offering of 3.5mm common shares, including the 150k share over-allotment, priced at $25 each. Selling shareholders are also offering 250k shares.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Glucose Testing
  • Medical Devices
    • Diagnostic Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies

UsernamePublicRestriction

Register